Estabrook Capital Management’s QIAGEN NV QGENF Stock Holding History

Estabrook Capital Management’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,050	Closed	-$113K	–	454
2016 Q4	$113K	Hold	4,050	–	–	0.02%	172
2016 Q3	$111K	Hold	4,050	–	–	0.02%	171
2016 Q2	$88.3K	Hold	4,050	–	–	0.01%	188
2016 Q1	$90.5K	Hold	4,050	–	–	0.01%	185
2015 Q4	$112K	Hold	4,050	–	–	0.02%	170
2015 Q3	$104K	Hold	4,050	–	–	0.02%	182
2015 Q2	$100K	Hold	4,050	–	–	0.01%	191
2015 Q1	$102K	Hold	4,050	–	–	0.01%	199
2014 Q4	$95K	Hold	4,050	–	–	0.01%	206
2014 Q3	$92.2K	Hold	4,050	–	–	0.01%	213
2014 Q2	$99K	Hold	4,050	–	–	0.01%	215
2014 Q1	$85.4K	Hold	4,050	–	–	0.01%	231
2013 Q4	$96.4K	Hold	4,050	–	–	0.01%	221
2013 Q3	$86.7K	Hold	4,050	–	–	0.01%	234
2013 Q2	$80.6K	Buy	+4,050	New	+$80.6K	0.01%	237

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Estabrook Capital Management's QGENF Position: Q1 2017 in Review

Estabrook Capital Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 4,050 shares — an estimated $113K sold.

Estabrook Capital Management first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $113K in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

Estabrook Capital Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
Estabrook Capital Management sold 4,050 QIAGEN NV shares in Q1 2017, an estimated $113K.
Estabrook Capital Management first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
Estabrook Capital Management's QIAGEN NV position peaked at $113K in Q4 2016.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Estabrook Capital Management's 13F filing for Q1 2017, filed 12 May 2017.